Genetic Fate Mapping Reveals Endothelial Cells During Venous Thrombus Resolution – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Magdalena L. Bochenek et al, adding:
“New RPTH research used a genetic fate mapping approach to visualize tamoxifen–inducible endothelial receptor tyrosine kinase (TIE2) reporter ECs during venous thrombus resolution and human pulmonary thrombi of different organizational stages to validate findings.
This time course analysis may aid the refinement of revascularization strategies in humans.
Tune in as co-authors Katrin Schäfer and Magdalena Bochenek discusses this new research with RPTH social media associate editor Nicolas Gendron.”
Title: Visualization of new vessel formation during venous thrombus organization using genetic fate mapping
Authors: Magdalena L. Bochenek, Julie D. Noorali, Aden Aderajew, Kateryna Moiko, Stefanie Zimmer, Konstantinos Zifkos, Mathias Wagner, Philipp Lurz, Lukas Hobohm, Katrin Schäfer
More posts featuring RPTH Journal on Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?